Adherence to prescribing guidelines in the primary prevention of cardiovascular disease and in the management of patients with type 2 diabetes in Qatar

Mohammad Issam Mahmmoud Diab, Julienne Johnson

Research output: Contribution to journalConference Contributionpeer-review


Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes in Dublin, Ireland, 19–21 October 2011. The prevalence of diabetes mellitus (DM) in the UK increased in 2009 to 4%, of which type-2 diabetes accounts for 85–95% of all cases. In Qatar the prevalence of DM among the adult Qatari population in 2008 was 16.7%; around four times higher than the prevalence in the UK. The aim of the study was to design and to apply a medication assessment tool (MAT) to determine the level of adherence to internationally recognised guideline recommendations in type-2 diabetes management and in primary prevention of cardiovascular disease (CVD) among type-2 diabetes patients, to quantify any gaps in guideline implementation.
Original languageEnglish
Pages (from-to)173-173
Number of pages1
JournalInternational Journal of Clinical Pharmacy
Issue number1
Publication statusPublished - Feb 2012


  • cardiovascular disease
  • type 2 diabetes
  • diabetes mellitus

Cite this